Alan R Smyth

13.9k citations

225 papers · 7.2k indexed · 4 hit papers · h-index 43

Impact in

Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Pulmonary and Respiratory Medicine top 0.2%
- Cystic Fibrosis Research Advances
- Tracheal and airway disorders
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery

Papers in

Pulmonary and Respiratory Medicine 165
- Cystic Fibrosis Research Advances 151
- Tracheal and airway disorders 39
- Inhalation and Respiratory Drug Delivery 22
- Neonatal Respiratory Health Research 20
Molecular Medicine 19
- Antibiotic Resistance in Bacteria 19

Co-authors: Matthew Hurley Andrew Prayle Simon C Langton Hewer Daan J. Touw Alan J. Knox John Britton Rosalind L. Smyth D P Heaf
Journals: Journal of Cystic Fibrosis (51 papers)Cochrane Database of Systematic Reviews (35 papers)Thorax (17 papers)Paediatric Respiratory Reviews (8 papers)Archives of Disease in Childhood (8 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Alan R Smyth

217 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Future therapies for cystic fibrosis 2023 · 71 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Communications
2015 Thorax
2015 Thorax
2014 Journal of Cystic Fibrosis

Peers

Countries citing papers authored by Alan R Smyth

Since Specialization

Citations

This map shows the geographic impact of Alan R Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R Smyth more than expected).

Fields of papers citing papers by Alan R Smyth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan R Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R Smyth. The network helps show where Alan R Smyth may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan R Smyth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan R Smyth Line = papers co-authored together Alan R Smyth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis Cochrane Database of Systematic Reviews ·Rebecca J Calthorpe, Sherie Smith, Nikki Jahnke, Alan R Smyth, (unknown)	2025	0
2	Distribution of tuberculosis in migrant children and young people in Europe: a retrospective database analysis of European data Public Health ·Patricia A. Payne, S E Hayward, Manish Pareek, Alan R Smyth, Lígia Regina Franco Sansigolo Kerr, Nuria Sánchez Clemente, Sally Hargreaves, Laura B Nellums	2024	1
3	Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis Journal of Cystic Fibrosis ·Ryan Marsh, Claudio Dos Santos, Alexander Yule, Neele Dellschaft, Caroline L. Hoad, Christabella Ng, Giles Major, Alan R Smyth, Damian Rivett, Chris Gast	2024	10
4	A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI) Journal of Cystic Fibrosis ·Alexander Yule, Christabella Ng, A. Flores Recto, Florence Lockwood, Neele Dellschaft, Caroline L. Hoad, Carlos Zagoya, Jochen G. Mainz, Giles Major, H. Barr, Penny Gowland, Iain Stewart, Luca Marciani, Robert E. Spiller, Alan R Smyth	2024	3
5	Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis Journal of Medical Microbiology ·Karmel Webb, Nur Masirah M. Zain, Iain Stewart, Andrew Fogarty, E.F. Nash, J.L. Whitehouse, Alan R Smyth, Andrew Lilley, Alan J. Knox, Paul Williams, Miguel Cámara, Kenneth D. Bruce, H. Barr	2022	9
6	Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT Health Technology Assessment ·Simon C Langton Hewer, Alan R Smyth, Michaela Brown, Ashley P Jones, Helen Hickey, D. Kenna, Deborah Ashby, Alexander Thompson, Laura Sutton, Dannii Clayton, Barbara Arch, Łukasz Tanajewski, Vladislav Berdunov, Paula Williamson	2021	7
7	Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis Thorax ·Katie J Bayfield, Tonia Douglas, Tim Rosenow, Jane C. Davies, J.S. Elborn, Marcus Mall, Anthony Paproki, Félix Ratjen, Peter D. Sly, Alan R Smyth, Stephen M. Stick, Claire Wainwright, Paul D. Robinson	2021	24
8	An ex vivo cystic fibrosis model recapitulates key clinical aspects of chronic Staphylococcus aureus infection Microbiology ·Esther Sweeney, Niamh E. Harrington, Alicia G. Harley Henriques, Marwa M. Hassan, Branagh Crealock-Ashurst, Alan R Smyth, Matthew Hurley, María Ángeles Tormo‐Más, Freya Harrison	2020	17
9	Antimicrobial resistance: Concerns of healthcare providers and people with CF Journal of Cystic Fibrosis ·Wendy Bullington, Sarah E. Hempstead, Alan R Smyth, Pavel Dřevı́nek, Lisa Saiman, Valerie J. Waters, Scott C. Bell, Donald R. VanDevanter, Patrick A. Flume, J.S. Elborn, Marianne S. Muhlebach	2020	12
10	Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging Journal of Cystic Fibrosis ·Christabella Ng, Neele Dellschaft, Caroline L. Hoad, Luca Marciani, Lu Ban, Andrew Prayle, H. Barr, Anke Jaudszus, Jochen G. Mainz, Robert E. Spiller, Penny Gowland, Giles Major, Alan R Smyth	2020	26
11	Staphylococcus aureus in cystic fibrosis Current Opinion in Pulmonary Medicine ·Matthew Hurley, Alan R Smyth	2018	10
12	The prevalence, clinical status and genotype of cystic fibrosis patients living in Cuba using national registry data Journal of Cystic Fibrosis ·Fidel Rodríguez-Calá, Ramón Suárez Medina, Silvia Josefina Venero Fernández, Alan R Smyth, S.B. Carr, Andrew Fogarty	2018	1
13	EPS1.9 Question CF: a James Lind Alliance Priority Setting Partnership in cystic fibrosis Journal of Cystic Fibrosis ·Nicola J. Rowbotham, Sherie Smith, M. McPhee, Zoe Elliott, Oliver Rayner, Paul Leighton, T. Daniels, Sarah Collins, Alistair Duff, E.F. Nash, M. Tabberner, Shreya Chandran, Ursula Peaple, Richard Morley, Alan R Smyth	2017	4
14	Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study BMJ Open ·Sally C Palser, Oliver Rayner, Paul Leighton, Alan R Smyth	2016	16
15	GLUTAMINE SUPPLEMENTATION FOR CYSTIC FIBROSIS - A RANDOMISED CONTROLLED TRIAL Pediatric Pulmonology ·Douglas L. Forrester, A. Knox, Alan R Smyth, Hugh Barr, Richard Simms, Sarah Pacey, Ian Pavord, D. Honeybourne, Andrew Fogarty	2011	1
16	Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent? Respiratory Medicine ·David Lo, Donald R. VanDevanter, Patrick A. Flume, Alan R Smyth	2011	16
17	Clinical trials in cystic fibrosis Journal of Cystic Fibrosis ·Gerd Döring, J.S. Elborn, Marie Johannesson, Hugo de Jonge, Matthias Griese, Alan R Smyth, Harry Heijerman	2007	36
18	Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus European Respiratory Journal ·Gerd Döring, S.P. Conway, Harry Heijerman, M.E. Hodson, Niels Høiby, Alan R Smyth, Daan J. Touw	2000	463
19	Paradoxical embolism in a boy with cystic fibrosis and a stroke Thorax ·Stephen Playfor, Alan R Smyth	1999	15
20	Clinical predictors of hypoxaemia in children with pneumonia Annals of Tropical Paediatrics ·Alan R Smyth, H. Carty, C. A. Hart	1998	67

About Alan R Smyth

Alan R Smyth is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine, Critical Care and Intensive Care Medicine, Speech and Hearing and Emergency Medical Services, having authored 225 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (151 papers), Tracheal and airway disorders (39 papers), Bacterial biofilms and quorum sensing (24 papers), Inhalation and Respiratory Drug Delivery (22 papers), Pneumonia and Respiratory Infections (21 papers), Neonatal Respiratory Health Research (20 papers), Antibiotic Resistance in Bacteria (19 papers) and Asthma and respiratory diseases (14 papers). The work is most often cited by research in Molecular Medicine (793 citations), Pulmonary and Respiratory Medicine (4.0k citations), Epidemiology (1.9k citations), Critical Care and Intensive Care Medicine (280 citations) and Speech and Hearing (318 citations). Alan R Smyth has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Matthew Hurley, Andrew Prayle, Simon C Langton Hewer, Daan J. Touw, Alan J. Knox, John Britton, Rosalind L. Smyth, D P Heaf, Jayesh Bhatt and Harry Heijerman. Their work appears in journals such as Journal of Cystic Fibrosis, Cochrane Database of Systematic Reviews, Thorax, Paediatric Respiratory Reviews and Archives of Disease in Childhood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact